BTC Health announces an exclusive distribution contract with Micrel Medical Devices.
BioImpact, a subsidiary of the company, has been granted exclusive sales and distribution rights to Rhythm Evolution infusion pumps in Australia and New Zealand.
The company anticipates the launch of this new product range in financial year 2024.
BTC Health is a leading player in the healthcare sector, with a critical focus on providing high-quality products and services in Australia and New Zealand.